Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second primary lung carcinoma

A Sulkes, Y Naparstek, M Shalit

    Journal of Surgical Oncology
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Second primary lung cancer is rare, but can occur years after initial treatment. This case highlights a 17-year interval, emphasizing the importance of long-term surveillance for bronchogenic carcinoma survivors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acute Monoblastic Leukemia with t(9;11) in a Patient Receiving Chemotherapy for Ovarian Cancer: Secondary Leukemia or Fortuitous Association of Two Neoplasias?

    Leukemia & lymphoma·2016
    Same author

    Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations.

    Breast cancer research and treatment·2016
    Same author

    A liposomal steroid nano-drug for treating systemic lupus erythematosus.

    Lupus·2016
    Same author

    PAGET'S DISEASE AND MALE BREAST CANCER.

    The Israel Medical Association journal : IMAJ·2015
    Same author

    Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2015
    Same author

    Familial Q fever clustering with variable manifestations imitating infectious and autoimmune disease.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
    Same journal

    Comparative Analysis of CEM and Breast MRI: A Retrospective Study.

    Journal of surgical oncology·2026
    Same journal

    The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

    Journal of surgical oncology·2026
    Same journal

    "It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

    Journal of surgical oncology·2026
    Same journal

    A Tale of Two Pathways: Same-Surgeon Versus Different-Surgeon Resection After Second Surgical Opinion.

    Journal of surgical oncology·2026
    Same journal

    How I Do It: The Life and Work of a Rubber Band in Robotic Liver Parenchymal Transection.

    Journal of surgical oncology·2026
    Same journal

    New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative Cancer Surgery.

    Journal of surgical oncology·2026
    See all related articles

    Area of Science:

    • Oncology
    • Pulmonology
    • Thoracic Surgery

    Background:

    • Bronchogenic carcinoma survivors are a small patient group.
    • Second primary lung cancers are rare, diagnosed simultaneously or sequentially.
    • Literature reports a median of 5 years between metachronous lung tumors.

    Observation:

    • A case of a second primary lung tumor diagnosed 17 years after initial treatment for bronchogenic carcinoma.
    • The first tumor was successfully treated with lobectomy.
    • The second tumor was located in the contralateral lung.

    Findings:

    • This case presents a longer-than-median interval (17 years) between primary and secondary lung tumors.
    • The rarity of such late-occurring metachronous lung cancers is highlighted.

    Related Experiment Videos

  • Histopathological and therapeutic aspects of these rare events are discussed.

    • Implications:

    • Long-term surveillance is crucial for bronchogenic carcinoma survivors.
    • The findings contribute to understanding the timeline and management of metachronous lung tumors.
    • Further research into the factors influencing late secondary lung cancer development is warranted.